Featured News

A new study from researchers at Penn State College of Medicine reveals significant differences in micronutrient deficiencies and healthcare utilization among minority patients with celiac disease (CeD) compared to their…

Newly released data from Chugai Pharmaceuticals shows their drug candidate DONQ52 potently blocks gluten-specific t-cells and is ready for continued development. So, what does this mean for the celiac disease community?

The future of celiac disease research is promising, with exciting advancements in diagnosis and therapies presented at the 2024 Digestive Disease Week® (DDW) conference in Washington, D.C. Read on for updates the Celiac Disease Foundation team gathered from lectures, posters, and panel discussions at the conference.

On May 20 the Disease Foundation hosted its third annual award reception at Digestive Disease Week in Washington, D.C. From prestigious global research prizes to inaugural student and policy leadership awards, the event spotlighted the extraordinary contributions of individuals dedicated to improving the lives of those affected by celiac disease.

The Celiac Disease Foundation is pleased to share important research and clinical trial news from Anokion, a biotechnology company evaluating a treatment for celiac disease. Using our iQualifyCeliac screening platform,…

Joining research studies and clinical trials is the only way to help scientists better understand this autoimmune disease and ultimately find a cure for celiac disease. This spring, I joined one of those important trials, funded by the Foundation, to help researchers with the development of a revolutionary new screening tool for celiac disease.

A new study conducted by researchers at the Cleveland Clinic and presented at the recent American College of Gastroenterology (ACG) meeting is shedding light on just how deeply celiac disease can impact a woman’s reproductive system.

This spring, the Celiac Disease Foundation was a title sponsor of the inaugural Asian Pacific Celiac Disease Symposium (APCDS) 2024. The conference drew professionals, researchers, and thought leaders from 16 countries to address key challenges in diagnosis and treatment of celiac disease in the Asia Pacific region.

The Celiac Disease Foundation is proud to share that for the second year in a row, access to funding for celiac disease research is being made available through the U.S. DOD Congressionally Directed Medical Research Programs (DOD-CDMRP)Peer Review Medical Research Program.

The Celiac Disease Foundation has joined forces with the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) Foundation to introduce two groundbreaking awards specifically designed to advance celiac disease research. These initiatives aim to foster novel research endeavors, emphasizing the importance for medical professionals to delve into the complexities of this lifelong autoimmune condition.